Es gab 50 kürzliche Insider-Transaktionen für Corcept Therapeutics Incorporated (CORT), darunter 24 Käufe und 20 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $56.64M und die gesamten Insider-Verkäufe auf $7.55M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Belanoff Joseph K, Wilson James N, Guyer William. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — CORT
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-25 |
Belanoff Joseph K |
Chief Executive Officer |
Informierter Verkauf |
26,198 |
$50.07 |
$1.31M |
2,918,326 |
| 2026-03-20 |
Wilson James N |
Director |
Schenkung (gegeben) |
4,000 |
- |
- |
1,102,532 |
| 2026-03-20 |
Guyer William |
Chief Development Officer |
Informierter Verkauf |
11,767 |
$36.01 |
$423.73K |
2,231 |
| 2026-03-17 |
Baker G Leonard Jr |
Director |
Informierter Kauf |
75,782 |
$33.00 |
$2.5M |
1,122,413 |
| 2026-03-13 |
Mahoney David L |
Director |
Optionsausübung (Verkauf) |
30,000 |
$5.86 |
$175.8K |
- |
| 2026-03-13 |
Wilson James N |
Director |
Schenkung (gegeben) |
28,000 |
- |
- |
1,106,532 |
| 2026-03-04 |
Guyer William |
Chief Development Officer |
Informierter Verkauf |
8,233 |
$35.99 |
$296.35K |
2,231 |
| 2026-03-03 |
Robb Gary Charles |
Chief Business Officer |
RSU-Steuereinbehalt |
121 |
$35.97 |
$4.35K |
79,503 |
| 2026-03-03 |
Mokari Atabak |
Chief Financial Officer |
RSU-Steuereinbehalt |
96 |
$35.97 |
$3.45K |
15,257 |
| 2026-03-03 |
Maduck Sean |
See Remarks |
RSU-Steuereinbehalt |
110 |
$35.97 |
$3.96K |
8,977 |
| 2026-03-03 |
Lyon Joseph Douglas |
See Remarks |
RSU-Steuereinbehalt |
89 |
$35.97 |
$3.2K |
11,230 |
| 2026-03-02 |
Robb Gary Charles |
Chief Business Officer |
RSU-Zuteilung |
499 |
$35.97 |
$17.95K |
79,125 |
| 2026-03-02 |
Mokari Atabak |
Chief Financial Officer |
RSU-Zuteilung |
397 |
$35.97 |
$14.28K |
14,956 |
| 2026-03-02 |
Maduck Sean |
See Remarks |
RSU-Zuteilung |
454 |
$35.97 |
$16.33K |
8,633 |
| 2026-03-02 |
Lyon Joseph Douglas |
See Remarks |
RSU-Zuteilung |
398 |
$35.97 |
$14.32K |
10,921 |
| 2026-03-02 |
Guyer William |
Chief Development Officer |
RSU-Zuteilung |
498 |
$35.97 |
$17.91K |
1,733 |
| 2026-02-27 |
Belanoff Joseph K |
Chief Executive Officer |
RSU-Zuteilung |
460,000 |
$35.70 |
$16.42M |
460,000 |
| 2026-02-27 |
Robb Gary Charles |
Chief Business Officer |
RSU-Zuteilung |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-27 |
Mokari Atabak |
Chief Financial Officer |
RSU-Zuteilung |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-27 |
Hunt Hazel |
Chief Scientific Officer |
RSU-Zuteilung |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-27 |
Maduck Sean |
See Remarks |
RSU-Zuteilung |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-27 |
Lyon Joseph Douglas |
See Remarks |
RSU-Zuteilung |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-27 |
Guyer William |
Chief Development Officer |
RSU-Zuteilung |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-24 |
Wilson James N |
Director |
Optionsausübung |
100,000 |
$3.88 |
$388K |
- |
| 2026-02-09 |
Hunt Hazel |
Chief Scientific Officer |
Optionsausübung (Verkauf) |
150,000 |
$3.88 |
$582K |
- |
| 2026-02-03 |
Guyer William |
Chief Development Officer |
Informierter Verkauf |
20,000 |
$40.87 |
$817.33K |
1,235 |
| 2026-01-27 |
Baker G Leonard Jr |
Director |
Optionsausübung (Verkauf) |
25,000 |
$10.50 |
$262.5K |
- |
| 2026-01-08 |
Maduck Sean |
See Remarks |
Schenkung (gegeben) |
34,000 |
- |
- |
5,147 |
| 2026-01-06 |
Guyer William |
Chief Development Officer |
Informierter Verkauf |
20,000 |
$35.18 |
$703.66K |
1,235 |
| 2026-01-01 |
Baker G Leonard Jr |
Director |
Schenkung (gegeben) |
- |
- |
- |
3,308,303 |
| 2025-12-24 |
Belanoff Joseph K |
Chief Executive Officer |
Schenkung (gegeben) |
243,154 |
- |
- |
- |
| 2025-12-24 |
Robb Gary Charles |
Chief Business Officer |
Optionsausübung (Verkauf) |
145,000 |
$3.88 |
$562.6K |
- |
| 2025-12-12 |
Wilson James N |
Director |
Sonstige (Kauf) |
200,000 |
- |
- |
200,000 |
| 2025-12-02 |
Mokari Atabak |
Chief Financial Officer |
RSU-Steuereinbehalt |
118 |
$79.78 |
$9.41K |
14,559 |
| 2025-12-02 |
Maduck Sean |
See Remarks |
RSU-Steuereinbehalt |
135 |
$79.78 |
$10.77K |
8,179 |
| 2025-12-02 |
Lyon Joseph Douglas |
See Remarks |
RSU-Steuereinbehalt |
110 |
$79.78 |
$8.78K |
10,523 |
| 2025-12-02 |
Guyer William |
Chief Development Officer |
Schenkung (gegeben) |
787 |
- |
- |
- |
| 2025-12-01 |
Robb Gary Charles |
Chief Business Officer |
RSU-Zuteilung |
224 |
- |
- |
14,058 |
| 2025-12-01 |
Mokari Atabak |
Chief Financial Officer |
RSU-Zuteilung |
178 |
$79.78 |
$14.2K |
14,499 |
| 2025-12-01 |
Maduck Sean |
See Remarks |
Informierter Verkauf |
20,000 |
$79.52 |
$1.59M |
7,904 |
| 2025-12-01 |
Lyon Joseph Douglas |
See Remarks |
Informierter Verkauf |
5,000 |
$79.53 |
$397.63K |
10,277 |
| 2025-12-01 |
Guyer William |
Chief Development Officer |
RSU-Zuteilung |
224 |
$79.78 |
$17.87K |
224 |
| 2025-06-16 |
Robb Gary Charles |
Chief Business Officer |
Informierter Verkauf |
3,185 |
$70.77 |
$225.4K |
13,364 |
| 2025-06-10 |
Baker G Leonard Jr |
Director |
RSU-Zuteilung |
15,000 |
$72.27 |
$1.08M |
15,000 |
| 2025-06-10 |
Mahoney David L |
Director |
RSU-Zuteilung |
15,000 |
$72.27 |
$1.08M |
15,000 |
| 2025-06-10 |
Wilson James N |
Director |
RSU-Zuteilung |
25,000 |
$72.27 |
$1.81M |
25,000 |
| 2025-06-10 |
Swisher Daniel N Jr |
Director |
Informierter Verkauf |
2,200 |
$70.61 |
$155.34K |
- |
| 2025-06-10 |
Alton Gregg H |
Director |
RSU-Zuteilung |
15,000 |
$72.27 |
$1.08M |
15,000 |
| 2025-06-10 |
Park Kimberly |
Director |
RSU-Zuteilung |
15,000 |
$72.27 |
$1.08M |
15,000 |
| 2025-06-10 |
Cannon Gillian |
Director |
RSU-Zuteilung |
15,000 |
$72.27 |
$1.08M |
15,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
